Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19 (BroVID)

NCT05276375 is registered in ClinicalTrials.gov with Dr. Frank Behrens as lead sponsor.

NCT NCT05276375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05276375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19 (BroVID)
Lead sponsor
Dr. Frank Behrens
Phase
Phase 2
Overall status
Completed
Start date
January 14, 2022
Completion date
June 30, 2023
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19